Hims & Hers Health: Super Bowl Advertisement Causes Controversies and Makes the Stock Soar
Reading Time: 3 minutes
• Provocative campaign with consequences: Hims & Hers’s aggressive advertising directly attacks the pharmaceutical industry and puts the company in the spotlight – with rising demand and heated regulatory debate. • Explosive share price increase, but high risks: The stock has rebounded by nearly 50% since January, but potential FDA interventions and transparency issues could impact the company's future. The telemedicine company Hims & Hers Health has not only garnered attention with a provocative Super Bowl advertisement, but...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
